Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
ESMO Open|August 20, 2019
Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTIMarkus Kieler, Matthias Unseld, Daniela Bianconi, et al.
Nature Communications|May 6, 2026
A single-cell atlas revealing cellular heterogeneity across healthy and diseased human thymusMartin Direder, Matthias Wielscher, Melanie Salek, et al.
Journal for Immunotherapy of Cancer|March 25, 2021
Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patientsAngelika M Starzer, Anna S Berghoff, Rainer Hamacher, et al.
Medicine|December 31, 2015
Impact of Single or Combined Genomic Alterations of TP53, MYC, and BCL2 on Survival of Patients With Diffuse Large B-Cell Lymphomas: A Retrospective Cohort StudyAna-Iris Schiefer, Christoph Kornauth, Ingrid Simonitsch-Klupp, et al.
Haematologica|July 10, 2012
ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 studyIlske Oschlies, Jasmin Lisfeld, Laurence Lamant, et al.
American Journal of Hematology|May 26, 2017
Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the diseaseGeorg Jeryczynski, Jürgen Thiele, Bettina Gisslinger, et al.
The American Journal of Surgical Pathology|April 1, 2011
Diagnosis and immunophenotype of 188 pediatric lymphoblastic lymphomas treated within a randomized prospective trial: experiences and preliminary recommendations from the European childhood lymphoma pathology panelIlske Oschlies, Birgit Burkhardt, Catherine Chassagne-Clement, et al.
Oncotarget|March 9, 2019
Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncologyGerald W Prager, Matthias Unseld, Fredrik Waneck, et al.
Cancers|May 13, 2023
Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC-Amplified Group 3 Medulloblastoma by Droplet Digital PCRNatalia Stepien, Daniel Senfter, Julia Furtner, et al.
Oncotarget|December 16, 2014
DNA methylation transcriptionally regulates the putative tumor cell growth suppressor ZNF677 in non-small cell lung cancersGerwin Heller, Corinna Altenberger, Bianca Schmid, et al.
Pageof 15